Literature DB >> 10727561

Primary biliary cirrhosis: new perspectives in diagnosis and treatment.

M I Prince1, D E Jones.   

Abstract

Primary biliary cirrhosis (PBC) is a chronic autoimmune disease characterised by cholestatic liver function tests, antimitochondrial antibodies, and abnormal liver histology. Early descriptions of a rare rapidly progressive disease no longer reflect the more indolent progress often seen today. Many patients have significant long term morbidity through symptoms such as fatigue and itch with a minority progressing to liver failure and need for transplantation. The current data on the diagnosis, clinical progression, and treatment of PBC are reviewed.

Entities:  

Mesh:

Year:  2000        PMID: 10727561      PMCID: PMC1741548          DOI: 10.1136/pmj.76.894.199

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  102 in total

1.  Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability.

Authors:  P M Grambsch; E R Dickson; M Kaplan; G LeSage; T R Fleming; A L Langworthy
Journal:  Hepatology       Date:  1989-11       Impact factor: 17.425

2.  Natural history of early primary biliary cirrhosis.

Authors:  J V Metcalf; H C Mitchison; J M Palmer; D E Jones; M F Bassendine; O F James
Journal:  Lancet       Date:  1996-11-23       Impact factor: 79.321

3.  Primary biliary cirrhosis.

Authors:  E H AHRENS; M A PAYNE; H G KUNKEL; W J EISENMENGER; S H BLONDHEIM
Journal:  Medicine (Baltimore)       Date:  1950-12       Impact factor: 1.889

4.  A study of antimitochondrial antibodies in a random population in Estonia.

Authors:  J M Turchany; R Uibo; T Kivik; J Van de Water; T Prindiville; R L Coppel; M E Gershwin
Journal:  Am J Gastroenterol       Date:  1997-01       Impact factor: 10.864

Review 5.  The clinical expression of primary biliary cirrhosis.

Authors:  J Heathcote
Journal:  Semin Liver Dis       Date:  1997-02       Impact factor: 6.115

6.  Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis.

Authors:  P Michieletti; I R Wanless; A Katz; P J Scheuer; S J Yeaman; M F Bassendine; J M Palmer; E J Heathcote
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

7.  A prospective clinical trial of D-penicillamine in the treatment of primary biliary cirrhosis.

Authors:  H C Bodenheimer; F Schaffner; I Sternlieb; F M Klion; S Vernace; J Pezzullo
Journal:  Hepatology       Date:  1985 Nov-Dec       Impact factor: 17.425

8.  Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits.

Authors:  P A Murtaugh; E R Dickson; G M Van Dam; M Malinchoc; P M Grambsch; A L Langworthy; C H Gips
Journal:  Hepatology       Date:  1994-07       Impact factor: 17.425

9.  Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment.

Authors:  D S Matloff; M M Kaplan; R M Neer; M J Goldberg; W Bitman; H J Wolfe
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

10.  Use of prognostic models for assessment of value of liver transplantation in primary biliary cirrhosis.

Authors:  G J Bonsel; I J Klompmaker; F van't Veer; J D Habbema; M J Slooff
Journal:  Lancet       Date:  1990-03-03       Impact factor: 79.321

View more
  10 in total

Review 1.  Fatigue in primary biliary cirrhosis.

Authors:  Ghulam Abbas; Roberta A Jorgensen; Keith D Lindor
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05-11       Impact factor: 46.802

Review 2.  Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

Review 3.  Pathogenesis of primary biliary cirrhosis.

Authors:  David E J Jones
Journal:  Gut       Date:  2007-07-19       Impact factor: 23.059

4.  Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort.

Authors:  D E J Jones; N Bhala; J Burt; J Goldblatt; M Prince; J L Newton
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

5.  Membranous nephropathy associated with primary biliary cirrhosis and acute meningitis.

Authors:  Shuzo Sato; Rie Saito; Haruyo Iwadate; Tomoyuki Asano; Kazumichi Abe; Atsushi Takahashi; Hiroko Kobayashi; Hiroshi Watanabe; Hiromasa Ohira
Journal:  Clin J Gastroenterol       Date:  2012-07-20

Review 6.  Primary biliary cirrhosis and liver transplantation.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara
Journal:  Intractable Rare Dis Res       Date:  2012-05

Review 7.  Treatment of pruritus associated with systemic disorders in the elderly: a review of the role of new therapies.

Authors:  Ann Lonsdale-Eccles; Andrew J Carmichael
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels.

Authors:  D M Forton; N Patel; M Prince; A Oatridge; G Hamilton; J Goldblatt; J M Allsop; J V Hajnal; H C Thomas; M Bassendine; D E J Jones; S D Taylor-Robinson
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

Review 9.  Primary biliary cirrhosis.

Authors:  Simon Hohenester; Ronald P J Oude-Elferink; Ulrich Beuers
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

Review 10.  Update on Emerging Treatment Options for Primary Biliary Cholangitis.

Authors:  Maria T Aguilar; David M Chascsa
Journal:  Hepat Med       Date:  2020-05-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.